Issues in the interpretation and design of studies investigating drug-related morbidity and mortality

Journal of Pharmacy Practice and Research

Volumn 32, Issue 3, 2002, Pages 235-239

  Easton Carter, Kylie L ^a,c   Chapman, Colin B ^b   Brian, Jo anne E ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c National Prescribing Service   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ADVERSE DRUG REACTION; ARTICLE; DATA ANALYSIS; DRUG FATALITY; DRUG SAFETY; HUMAN; MEDICAL DECISION MAKING; METHODOLOGY; MORBIDITY; MORTALITY; PATIENT MONITORING; PATIENT SELECTION;

EID: 0036761018     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jppr2002323235     Document Type: Article

References (72)

1. Raschetti R, Morgutti M, Menniti-Ippolito F, Belisari A, Rossignoli A, Longhini P, et al. Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol 1999: 54: 959-63.
2. Tafreshi MJ, Melby MJ, Kaback KR, Nord TC. Medication-related visits to the emergency department: A prospective study. Ann Pharmacother 1999; 33: 1252-7.
3. Dennehy CE, Kishi DT, Louie C. Drug-related illness in emergency department patients. Am J Health Syst Pharm 1996; 53: 1422-6.
4. Ng D, Cosh DG, Harris J, Whitehead C. Unplanned medication-related admissions to an acute care general teaching hospital. Aust J Hosp Pharm 1999; 29: 84-7.
5. Dartnell JGA, Anderson RP, Chohan V, Galbraith KJ, Lyon ME, Nestor PJ, et al. Hospitalisation for adverse events related to drug therapy: Incidence, avoidability and costs. Med J Aust 1996: 164: 659-62.
6. Larmour I, Dolphin RG, Baxter H, Morrison S, Hooke DH, McGrath BP. A prospective study of hospital admissions due to drug reactions. Aust J Hosp Pharm 1991; 21: 90-5.
7. Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD, Drug-related problems: Their structure and function. DICP 1990; 24: 1093-7.
8. Edwards IR, Biriell C. Harmonisation in pharmacovigilance. Drug Saf 1994; 10: 93-102.
9. Roughead EE, Gilbert AL, Primrose JG, Harvey KJ, Sampson LN. Report of the National Indicators: Evaluating the Quality Use of Medicines Component of Australia's National Medicines Policy, Canberra: Publications Production Unit (Public Affairs, Parliamentary and Access Branch); 1999.
10. Roughead EE, Gilbert AL, Primrose JG, Sansom LN. Coding drug-related admissions in medical records: Is it adequate for monitoring the quality of medication use? Aust J Hosp Pharm 1998; 28: 7-12.
11. Roughead EE, Gilbert AL, Primrose JG, Sansom LN. Drug-related hospital admissions: A review of Australian studies published 1988-1996. Med J Aust 1998; 168: 405-8.
12. Roughead E. The nature and extent of drug-related hospitalisations in Australia. J Qual Clin Pract 1999; 19: 19-22.
13. Hallas J, Harvald B, Worm J, Beck-Nielsen J, Gram LF, Grodum E, et al. Drug related hospital admissions: Results from an intervention program. Eur J Clin Pharmacol 1993; 45: 199-203.
14. Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacotherapy 1996: 16: 701-7.
15. Smith KM, McAdams JW, Frenia ML, Todd MW. Drug-related problems in emergency department patients. Am J Health Syst Pharm 1997; 54: 295-8.
16. Johnson JA, Bootman JL. Drug-related morbidity and mortality: A cost-of-illness model. Ann Intern Med 1995; 155: 1949-56.
17. Johnson JA, Bootman JL. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health Syst Pharm 1997; 54: 554-8.
18. Rothschild JM, Bates DW, Leape LL. Preventable medical injuries in older patients. Arch Intern Med 2000: 160: 2717-28.
19. Bootman JL, Harrison DL, Cox E. The health care cost of drug-related morbidity and mortality in nursing homes. Arch Intern Med 1997; 157: 2089-96.
20. Day R, Use of non steroidal anti-inflammatory drugs. Proceedings of the Reducing Adverse Drug Events in the Australian Health Care System Conference, South Australian Department of Human Services and the Australian Department of Health and Family Services; 1998; Adelaide, Australia.
21. Gallus A, Use of anticoagulants. Proceedings of the Reducing Adverse Drug Events in the Australian Health Care System Conference, South Australian Department of Human Services and the Australian Department of Health and Family Services; 1998; Adelaide, Australia.
22. Hallas J, Harvald B, Gram LF, Grodum E. Brosen K. Haghfelt T. et al. Drug related hospital admissions: The role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990; 228: 83-90.
23. Bates DW. Drugs and adverse drug reactions: How worried should we be? JAMA 1998; 279: 1216-17.
24. Kramer MS. Difficulties in assessing the adverse effects of drugs. Br J Clin Pharmacol 1981; 11 (suppl. 1): S105-S110.
25. Schneitman-McIntire O, Farnen TA, Gordon N, Chan J, Toy WA. Medication misadventures resulting in emergency department visits at an HMO medical center. Am J Health Syst Pharm 1996; 53: 1416-22.
26. Prince BS, Goetz CM, Rihn TL, Olsky M. Drug-related emergency department visits and hospital admissions. Am J Hosp Pharm 1992; 49: 1696-700.
27. Galbraith K. Is There a Role for a Clinical Pharmacist in the Emergency Department? [Grad Dip Hosp Pharm thesis]. Melbourne: Victorian College of Pharmacy, Monash University: 1993.
28. Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993; 27: 832-40.
29. Stephens MDB. Introduction. In: Stephens MDB. Talbot JCC, Routledge PA, editors. Detection of New Adverse Drug Reactions. 4th Ed. London: MacMillan Publishers; 1998: p. 1-58.
30. Hallas J, Gram LF, Grodum E, Damsbo N, Brosen K, Haghfelt T et al. Drug related admissions to medical wards: A population based survey. Br J Clin Pharmacol 1992; 33: 61-8.
31. Atkin PA, Shenfield GM. Medication-related adverse reactions and the elderly: A literature review. Adverse Drug React Toxicol Rev 1995; 14: 175-91.
32. Miller RR. Drug surveillance utilizing epidemiologic methods: A report from the Boston Collaborative Drug Surveillance Program. Am J Hosp Pharm 1973; 30: 584-92.
33. Whyte J, Greenan E. Drug usage and adverse drug reactions in paediatric patients. Acta Paediatr Scand 1977; 66: 767-75.
34. Mitchell AA, Lacouture PG, Sheehan JE. Kauffman RE, Shapiro S. Adverse drug reactions in children leading to hospital admission. Pediatrics 1988; 82: 24-9.
35. Mitchell AA. Goldman P, Shapiro S, Slone D. Drug utilization and reported adverse reactions in hospitalized children. Am J Epidemiol 1979; 110: 196-204.
36. Conroy S, Choonara I, Impicciatore P, Mohn A, Amell H, Rane A, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ 2000; 320: 79-82.
37. Boston Collaborative Drug Surveillance Program of the Boston University Medical Center. Drug surveillance. Problems and challenges, Pediatr Clin North Am 1972; 19: 117-29.
38. McKenzie MW, Stewart RB, Weiss CF, Cluff LE. A pharmacist-based study of the epidemiology of adverse drug reactions in pediatric medicine patients. Am J Hosp Pharm 1973; 30: 898-903.
39. Karch FE, Lasagna L. Adverse drug reactions: A critical review. JAMA 1975; 234: 1236-41.
40. Muelhlberger N, Schneeweiss S, Hasford J. Adverse drug reaction monitoring - Cost and benefit considerations part I: Frequency of adverse drug reactions causing hospital admissions. Pharmacoepidemiology Drug Saf 1997; 6: S71-S77.
41. Jha AK, Kuperman GJ, Teich JM, Leape L, Shea B, Rittenberg E, et al. Identifying adverse drug events: Development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc 1998; 5: 305-14.
42. Schlienger RG, Luscher TF, Schoenenberger RA, Haefeli WE. Academic detailing improves identification and reporting of adverse drug events. Pharm World Sci 1999; 21: 110-5.
43. Stowasser DA, Staatz CE, Stowasser M, Coombes JA, Collins DM. Identifying drug-related readmissions: Is there a better way of assessing the contribution of adverse medication events? Aust J Hosp Pharm 2000; 30: 47-53.
44. Venulet J, ten Ham M. Methods for monitoring and documenting adverse drug reactions. Int J Clin Pharmacol Ther 1996; 34: 112-29.
45. Stather R. Spontaneous reporting of ADRs - the Australian perspective. Reactions 1996; 615: 3-4.
46. Choonara I, Gill A, Nunn A. Drug toxicity and surveillance in children. Br J Clin Pharmacol 1996; 42: 407-10.
47. Hewitt J. Drug-related unplanned readmissions to hospital. Aust J Hosp Pharm 1995; 25: 400-3.
48. Blackbourn J. Readmission to Fremantle Hospital. Part II - Drug-Related Readmissions. Fremantle: Fremantle Hospital, 1991.
49. Koch-Weser J, Sellers EM, Zaces R. The ambiguity of adverse drug reactions. Eur J Clin Pharmacol 1977; 11: 75-8.
50. Hutchinson TA, Lane DA. Assessing methods for causality assessment of suspected adverse drug reactions. J Clin Epidemiol 1989; 42: 5-16.
51. Stephens MDB. The diagnosis of adverse medical events associated with drug treatment. Adverse Drug React Acute Poisoning Rev 1987; 6: 1-35.
52. Stephens MDB. editor. Detection of new adverse drug reactions. 3rd ed. Hampshire: MacMillan Publishers: 1992.
53. Meyboom RHB, Hekster YA, Egberts ACG, Gribnau FWJ, Edwards IR. Causal or casual? The role of causality assessment in pharmacovigilance. Drug Saf 1997; 17: 374-89.
54. Castle W. Adverse drug reactions: Scope and limitations of causality assessments and the use of algorithms. Int J Risk Saf Med 1991; 2: 185-92.
55. Hutchinson TA. Standardized assessment methods for adverse drug reactions: A review of previous approaches and their problems. Drug Inf J 1986; 20: 439-44.
56. Lanctot KL, Naranjo CA, Comparison of the Bayesian approach and a simple algorithm for assessment of adverse drug events. Clin Pharmacol Ther 1995; 58: 692-8.
57. Venulet J. Aspects of standardization as applied to the assessment of drug-event associations. Drug Inf J 1984; 18: 199-210.
58. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45.
59. Schneider PJ, Hartwig SC. Use of severity-indexed medication error reports to improve quality. Hosp Pharm 1994; 29: 208-11.
60. Gholami K, Shalviri G. Factors associated with preventability, predictability, and severity of adverse drug reactions. Ann Pharmacother 1999; 33: 236-40.
61. Zilleruelo I, Espinoza E, Ruiz I. Influence of the assessment of the severity on the frequency of adverse drug reactions (ADRs). Int J Clin Pharmacol Ther Toxicol 1987; 25: 328-33.
62. Stoukides CA, D'Agostino PR, Kaufman MB. Adverse drug reaction surveillance in an emergency room. Am J Health Syst Pharm 1993; 50: 712-14.
63. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events: Implications for prevention. ADE Prevention Study Group, JAMA 1995; 274: 29-34.
64. Cullen DJ, Sweitzer BJ, Bates DW, Burdick E, Edmondson A, Leape LL. Preventable adverse drug events in hospitalized patients: A comparative study of intensive care and general care units. Crit Care Med 1997; 25: 1289-97.
65. Bates D, Leape LL, Cullen DJ, Laird N, Petersen LA, Teich JM, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998; 280: 1311-16.
66. Kramer MS, Hutchinson TA, Flegel KM, Naimark L, Contardi R, Leduc DG. Adverse drug reactions in general pediatric outpatients. J Pediatr 1985; 106: 305-10.
67. Seeger JD, Kong SX, Schumock GT. Characteristics associated with the ability to prevent adverse drug reactions in hospitalized patients. Pharmacotherapy 1998; 18: 1284-9.
68. Rawlins MD, Thompson JW. Pathogenesis of adverse drug reactions. Davies DM. editor, Textbook of adverse drug reactions. Oxford: Oxford University Press; 1977. p 10-31.
69. Wills S, Brown D. A proposed new means of classifying adverse reactions to medicines. Pharm J 1999; 262: 163-5.
70. Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992; 27: 538.
71. Pearson TF, PIttman DG, Longley JM, Grapes ZT, Vigliotfi DJ, Mullis SR. Factors associated with preventable adverse drug reactions. Am J Hosp Pharm 1994; 51: 2268-72.
72. Johnstone DM, Kirking DM, Vinson BE. Comparison of adverse drug reactions detected by pharmacy and medical record departments. Am J Health Syst Pharm 1995; 52: 297-301.